# Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries

**Authors:** Gautam Satheesh, Bishal Gyawali, Marie France Chan Sun, Mark D. Huffman, Amitava Banerjee, Pablo Perel, Adrianna Murphy

PMC · DOI: 10.5334/gh.1350 · Global Heart · 2024-08-13

## TL;DR

This paper corrects a previously published survey on the availability and affordability of polypills for cardiovascular disease in several countries.

## Contribution

The paper provides a correction to a prior study, ensuring accuracy in the survey's findings and references.

## Key findings

- The original survey findings on polypill availability and affordability remain unchanged.
- The correction addresses errors in the original publication's references and formatting.
- No new data was collected; the correction focuses on improving the integrity of the published work.

## Abstract

This article details a correction to: Satheesh, G., Gyawali, B., Sun, M.F.C., Huffman, M.D., Banerjee, A., Perel, P. and Murphy, A. (2024) ‘A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries’. Global Heart. 19(1):p. 56. Available at: https://doi.org/10.5334/gh.1335.

## Linked entities

- **Diseases:** Cardiovascular Disease (MONDO:0004995)

## Full-text entities

- **Diseases:** Cardiovascular Disease (MESH:D002318)
- **Chemicals:** Polypills (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11328679/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC11328679/full.md

---
Source: https://tomesphere.com/paper/PMC11328679